Alnylam Pharmaceuticals
ALNY
#443
Rank
NZ$91.54 B
Marketcap
NZ$692.91
Share price
1.06%
Change (1 day)
63.24%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company